Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Boland

Showing results (511-520 of 571) with videos related to

Pageof 58
Sort By:
Nature Immunology|July 31, 2019
PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1<sup>+</sup>CD38<sup>hi</sup> cells and anti-PD-1 resistanceVivek Verma, Rajeev K Shrimali, Shamim Ahmad, et al.
Nature Immunology|September 26, 2019
Author Correction: PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1<sup>+</sup>CD38<sup>hi</sup> cells and anti-PD-1 resistanceVivek Verma, Rajeev K Shrimali, Shamim Ahmad, et al.
Nature|July 22, 2021
Phenotype, specificity and avidity of antitumour CD8<sup>+</sup> T cells in melanomaGiacomo Oliveira, Kari Stromhaug, Susan Klaeger, et al.
NPJ Precision Oncology|November 1, 2022
Prediction of early-stage melanoma recurrence using clinical and histopathologic featuresGuihong Wan, Nga Nguyen, Feng Liu, et al.
Cancer Immunology Research|January 9, 2025
TBK1 Targeting Is Identified as a Therapeutic Strategy to Enhance CAR T-Cell Efficacy Using Patient-Derived Organotypic Tumor SpheroidsYi Sun, Luke Maggs, Apekshya Panda, et al.
Nature Communications|July 14, 2022
HRS phosphorylation drives immunosuppressive exosome secretion and restricts CD8<sup>+</sup> T-cell infiltration into tumorsLei Guan, Bin Wu, Ting Li, et al.
Nature Biomedical Engineering|February 11, 2026
Ablation of prostaglandin E<sub>2</sub> signalling through dual receptor knockout in CAR T cells enhances therapeutic efficacy in solid tumoursJanina Dörr, Lisa Gregor, Sebastian B Lacher, et al.
Nature|May 4, 2022
Landscape of helper and regulatory antitumour CD4<sup>+</sup> T cells in melanomaGiacomo Oliveira, Kari Stromhaug, Nicoletta Cieri, et al.
Science Advances|January 10, 2025
Ultrasensitive detection of intact SARS-CoV-2 particles in complex biofluids using microfluidic affinity captureDaniel C Rabe, Adarsh Choudhury, Dasol Lee, et al.
Oncotarget|April 28, 2017
Context-dependent miR-204 and miR-211 affect the biological properties of amelanotic and melanotic melanoma cellsMarianna Vitiello, Andrea Tuccoli, Romina D'Aurizio, et al.
Pageof 58

Showing results (511-520 of 571) with videos related to

Sort By:
Pageof 58
Nature Immunology|July 31, 2019
PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1<sup>+</sup>CD38<sup>hi</sup> cells and anti-PD-1 resistanceVivek Verma, Rajeev K Shrimali, Shamim Ahmad, et al.
Nature Immunology|September 26, 2019
Author Correction: PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1<sup>+</sup>CD38<sup>hi</sup> cells and anti-PD-1 resistanceVivek Verma, Rajeev K Shrimali, Shamim Ahmad, et al.
Nature|July 22, 2021
Phenotype, specificity and avidity of antitumour CD8<sup>+</sup> T cells in melanomaGiacomo Oliveira, Kari Stromhaug, Susan Klaeger, et al.
NPJ Precision Oncology|November 1, 2022
Prediction of early-stage melanoma recurrence using clinical and histopathologic featuresGuihong Wan, Nga Nguyen, Feng Liu, et al.
Cancer Immunology Research|January 9, 2025
TBK1 Targeting Is Identified as a Therapeutic Strategy to Enhance CAR T-Cell Efficacy Using Patient-Derived Organotypic Tumor SpheroidsYi Sun, Luke Maggs, Apekshya Panda, et al.
Nature Communications|July 14, 2022
HRS phosphorylation drives immunosuppressive exosome secretion and restricts CD8<sup>+</sup> T-cell infiltration into tumorsLei Guan, Bin Wu, Ting Li, et al.
Nature Biomedical Engineering|February 11, 2026
Ablation of prostaglandin E<sub>2</sub> signalling through dual receptor knockout in CAR T cells enhances therapeutic efficacy in solid tumoursJanina Dörr, Lisa Gregor, Sebastian B Lacher, et al.
Nature|May 4, 2022
Landscape of helper and regulatory antitumour CD4<sup>+</sup> T cells in melanomaGiacomo Oliveira, Kari Stromhaug, Nicoletta Cieri, et al.
Science Advances|January 10, 2025
Ultrasensitive detection of intact SARS-CoV-2 particles in complex biofluids using microfluidic affinity captureDaniel C Rabe, Adarsh Choudhury, Dasol Lee, et al.
Oncotarget|April 28, 2017
Context-dependent miR-204 and miR-211 affect the biological properties of amelanotic and melanotic melanoma cellsMarianna Vitiello, Andrea Tuccoli, Romina D'Aurizio, et al.
Pageof 58